Effects of omega-3 fatty acids on lipids and glycemic control in type II diabetes and the metabolic syndrome and on inflammatory bowel disease, rheumatoid arthritis, renal disease, systemic lupus erythematosus, and osteoporosis

Evid Rep Technol Assess (Summ). 2004 Mar;(89):1-4.
No abstract available

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Adult
  • Anti-Inflammatory Agents / therapeutic use
  • Arthritis, Rheumatoid / diet therapy*
  • Arthritis, Rheumatoid / drug therapy
  • Bone Density
  • Child
  • Diabetes Mellitus, Type 2 / diet therapy*
  • Diabetes Mellitus, Type 2 / metabolism
  • Fatty Acids, Omega-3 / pharmacology*
  • Fatty Acids, Omega-3 / physiology
  • Fatty Acids, Omega-3 / therapeutic use
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Inflammatory Bowel Diseases / diet therapy*
  • Inflammatory Bowel Diseases / drug therapy
  • Kidney Diseases / diet therapy*
  • Kidney Diseases / drug therapy
  • Lupus Erythematosus, Systemic / diet therapy*
  • Meta-Analysis as Topic
  • Metabolic Syndrome / diet therapy*
  • Metabolic Syndrome / metabolism
  • Osteoporosis / diet therapy*
  • Placebos
  • Randomized Controlled Trials as Topic

Substances

  • Adrenal Cortex Hormones
  • Anti-Inflammatory Agents
  • Fatty Acids, Omega-3
  • Immunosuppressive Agents
  • Placebos